Skip to main content
. 2017 Aug 30;6(10):e1315486. doi: 10.1080/2162402X.2017.1315486

Figure 4.

Figure 4.

PET-CT showing tumor central necrosis and pseudoprogression in a patient recruited in the Phase 1 clinical trial. The pathology report indicated that the rim was >90% necrotic suggesting an influx of lymphocytes.